EUVIMEDEUVIMED entdecken
Crossref

Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis

Peng He iD, Chengming Wen iD, Xinyu Zhang, Hang Yin iD

Journal of Medicinal Chemistry · 13.03.2025 · 68 (5) · 5551-5572

DOI: 10.1021/acs.jmedchem.4c02774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.02.2025. Verfasst von Peng He und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Sciences, Key Laboratory of Bioorganic P…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Nucleotidyltransferases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Beijing Outstanding Young Scientist Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclic GMP-AMP synthase (cGAS), a critical cytosolic DNA sensor initiating innate immune responses in the presence of cytosolic DNA, is increasingly recognized as a promising therapeutic target for ulcerative colitis (UC). Here, we reported the design, synthesis, structure-activity relationship exploration and biological evaluation of a novel class of CRBN-recruiting cGAS-targeting PROTAC degraders. Among them, TH35 exhibited the most favorable degradation profile, achieving potent and selective degradation of cGAS, and markedly attenuated dsDNA-induced activation of cGAS signaling in both human and murine cells, with minimal cytotoxic effects. In vivo, TH35 demonstrated superior therapeutic efficacy in a dextran sulfate sodium (DSS)-induced mouse model of UC compared to the corresponding cGAS inhibitor, while also displaying acceptable pharmacokinetic properties. Collectively, TH35 as the first CRBN-recruiting cGAS PROTAC holds promise for augmenting anti-inflammatory responses and offers a new avenue for treating cGAS-driven inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeNucleotidyltransferasesAnimalsHumansMiceStructure-Activity RelationshipAdaptor Proteins, Signal TransducingDextran SulfateMice, Inbred C57BLDrug DiscoveryUbiquitin-Protein LigasesProteolysisCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Substanzen

NucleotidyltransferasesAdaptor Proteins, Signal TransducingDextran SulfateUbiquitin-Protein LigasescGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseCRBN protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Sciences, Key Laboratory of Bioorganic Phosphorous Chemistry and Chemical Biology (Ministry of Education), Tsi…

ORCID-Profile: Peng He, Chengming Wen, Hang Yin

Förderung

  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Beijing Outstanding Young Scientist Program
  • the China Postdoctoral Science Foundation
  • the Postdoctoral Fellowship Program of CPSF
  • the Natural Science Foundation of Beijing, China

Zitieren

APA

He, P., Wen, C., Zhang, X., & Yin, H. (2025). Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis. Journal of Medicinal Chemistry, 68(5), 5551-5572. https://doi.org/10.1021/acs.jmedchem.4c02774

Vancouver

He P, Wen C, Zhang X, Yin H. Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis. Journal of Medicinal Chemistry. 2025;68(5):5551-5572. doi:10.1021/acs.jmedchem.4c02774

BibTeX
@article{He2025,
  author = {He, Peng and Wen, Chengming and Zhang, Xinyu and Yin, Hang},
  title = {Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {5},
  pages = {5551--5572},
  doi = {10.1021/acs.jmedchem.4c02774}
}
Kostenlos starten →